您的位置: 首页 > 农业专利 > 详情页

Monocarboxylate transporter 4 (MCT4) antisense oligonucleotide (ASO) inhibitors for use as therapeutics in the treatment of cancer
专利权人:
The University of British Columbia
发明人:
Wang, Yuzhuo,Choi, Stephen Yiu Chuen,Gleave, Martin E.,Xue, Hui,Collins, Colin C.,Gout, Peter Wilhelm
申请号:
AU2016363683
公开号:
AU2016363683A1
申请日:
2016.11.30
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
Provided herein are compositions, method and uses for modulating MCT4 activity or for the treatment of cancer. The compositions comprise antisense oligonucleotides (ASO) for administration to a cancer cell, wherein the cancer cell may be characterized by elevated expression of MCT4. The cancer may be selected from one or more of: prostate cancer renal cell carcinoma breast cancer cervical cancer liver cancer bladder cancer and small cell lung cancer pr. The prostate cancer may be castration-resistant prostate cancer (CRPC).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充